KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Treasury Shares (2019 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Treasury Shares for 4 consecutive years, with $22.8 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Treasury Shares fell 15.2% year-over-year to $22.8 million, compared with a TTM value of $22.8 million through Sep 2023, down 15.2%, and an annual FY2022 reading of $23.5 million, down 86.03% over the prior year.
  • Treasury Shares was $22.8 million for Q3 2023 at Ginkgo Bioworks Holdings, down from $23.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $197.1 million in Q1 2023 and bottomed at -$2.7 million in Q3 2021.
  • Average Treasury Shares over 4 years is $46.4 million, with a median of $22.9 million recorded in 2023.
  • The sharpest move saw Treasury Shares crashed 100.0% in 2022, then soared 24506.35% in 2023.
  • Year by year, Treasury Shares stood at $490805.0 in 2019, then skyrocketed by 34195.08% to $168.3 million in 2021, then plummeted by 100.0% to $4000.0 in 2022, then soared by 569600.0% to $22.8 million in 2023.
  • Business Quant data shows Treasury Shares for DNA at $22.8 million in Q3 2023, $23.0 million in Q2 2023, and $197.1 million in Q1 2023.